Be the Match BioTherapies
1 / 1
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01Dec 14, 2023
Cell and Gene Therapy Distribution
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies
PR-M10-23-03-44Oct 13, 2023
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01Sep 15, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02Sep 15, 2023
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Pharma's Almanac
PAO-07-23-RT-01Jul 21, 2023
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
Pharma's Almanac
PAO-07-23-RT-02Jul 21, 2023
Cord Blood Bank Alliance
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
Be The Match BioTherapies
PR-M07-23-01Jul 13, 2023
Allogeneic Cell Therapy Logistics
Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement
Joy Aho, Ph.D.
Be The Match BioTherapies
PAO-06-23-CL-06Jun 27, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02Jan 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01Jan 31, 2023
Cell Therapy
Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
Chris McClain
Be The Match BioTherapies
PAO-11-022-CL-01Nov 01, 2022
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02Oct 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01Oct 11, 2022
Cord Blood
Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use
Be The Match BioTherapies
PR-M08-22-02Aug 13, 2022
Strategic Partnership
Chimeric Partners With Be The Match BioTherapies® To Advance CHM 1101 (CLTX CAR T)
Chimeric Therapeutics
PR-M03-22-07Mar 17, 2022
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
Amy L. Ronneberg
Be The Match BioTherapies
PAO-02-022-CL-12Mar 12, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734Dec 20, 2021
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Chris McClain
Be The Match BioTherapies
PAO-09-21-CL-04Sep 09, 2021
1 / 1